This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Kaneka Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: **Innovations of Keishi Takatsu: A Pioneer in Ribosome Display Technology**
Introduction
Keishi Takatsu, located in Hyogo, Japan, is an innovative inventor recognized for his significant contributions to biochemistry and molecular biology. With a strong focus on ribosome display technology, he has developed methods that advance our understanding of protein synthesis and its applications in various fields.
Latest Patents
Takatsu holds one notable patent titled "Ribosome display complex and production method therefor." This patent describes a sophisticated method for producing a ribosome display complex. The process involves obtaining a ribosome complex that includes an unmodified polypeptide chain, mRNA molecule, and ribosome. By initiating translation of the mRNA in a cell-free peptide synthesis system, Takatsu's method modifies the polypeptide chain using a reactive functional group. The invention particularly emphasizes the use of reactive amino acids such as cysteine, lysine, histidine, and tryptophan, enhancing the potential of ribosome display technology.
Career Highlights
Keishi Takatsu is affiliated with Kaneka Corporation, a leading company in innovative materials and bioproducts. His work focuses on the intersection of chemistry and biology, paving the way for breakthroughs in therapeutic and diagnostic applications. He has made substantial strides in understanding the intricacies of ribosome functions and their implications in protein engineering.
Collaborations
Throughout his career, Takatsu has collaborated with esteemed colleagues, including Hiroshi Kita and Toshihiro Shikakura. These partnerships have been vital in fostering a creative environment for research and innovation, leading to advancements in biotechnological applications.
Conclusion
Keishi Takatsu exemplifies the spirit of innovation in modern scientific research. With a unique patent enhancing ribosome display technology, he continues to impact the fields of biochemistry and molecular biology significantly. His work at Kaneka Corporation, along with collaborations with colleagues, showcases the importance of teamwork in driving scientific progress and developing practical applications for advanced biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile